Riskpilot← Back to searchSign inGet full accessDoc&Dog AB
ABActiveOrg 5569793879Fåglabo StenkullenGeneral medical practice activities · NACE 8621Est. 20140 employees
Revenue 2025
SEK 288K
+95% vs 2024
EBITDA margin
80.6%
+107% vs 2024
Equity ratio
52.1%
Financial strength
Net profit 2025
SEK 186K
+98% vs 2024
| Revenue | SEK 288K | +95% |
| EBITDA | SEK 232K | +107% |
| Net profit | SEK 186K | +98% |
| Total assets | SEK 608K | +3% |
| Equity | SEK 317K | -7% |
| Employees | 0 | — |
Legal name
Doc&Dog AB
Org number
5569793879
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 augusti 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget skall bedriva hunduppfödning inklusive konsultverksamhet inom hundbranschen, hyra ut vårdpersonal samt köpa och sälja aktier och aktiefonder och liknande.
Address
Fåglabo Stenkullen
Email
malvashusse@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 175 | 173 | 237 | 148 | 288 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 112 | 122 | 159 | 112 | 232 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 112 | 122 | 159 | 112 | 232 |
| Net financials | — | — | 2 | 6 | 2 |
| Profit before tax | 112 | 122 | 161 | 118 | 234 |
| Tax | −24 | −25 | −33 | −24 | −48 |
| Net profit | 88 | 97 | 128 | 94 | 186 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 646 | 565 | 516 | 590 | 608 |
| Equity | 606 | 519 | 452 | 342 | 317 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 39 | 46 | 64 | 249 | 291 |
| Total debt | 39 | 46 | 64 | 249 | 291 |
EBITDA margin
80.6%
This company
15.8%
Market median
+410% vs market
20212025
Equity ratio
52.1%
This company
38.2%
Market median
+36% vs market
20212025
Return on equity
58.7%
This company
18.4%
Market median
+219% vs market
20212025
Net profit margin
64.6%
This company
8.1%
Market median
+698% vs market
20212025
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20212025
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EU Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doc&Dog AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erling Ulrik Edvinsson | Chief Executive Officer | 0 companies |
| Christine Edvinsson | Board of Directors | 0 companies |